ScholarIQanswers from OpenAlex

Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS)

PaperCitations, authors & open-access status

Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) have?

ScholarIQcitation count

Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) published?

ScholarIQyear

Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) has 2023 year in the ScholarIQ index.

What is the open-access status of Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS)?

ScholarIQoa status

Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) has bronze oa status in the ScholarIQ index.

What is the DOI of Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS)?

ScholarIQdoi

The DOI for Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) is on the source record.

What is the OpenAlex record for Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS)?

ScholarIQopenalex

The OpenAlex for Population PK and exposure-response (ER) analyses to support dosing of teduglutide in infant patients with short bowel syndrome (SBS) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial